Evidence map›Paper›PMID 28900777›Full record

ReviewFamilial cancer2018

An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review.

Julian Daniell, John-Paul Plazzer, Anuradha Perera, Finlay Macrae

Abstract readReview
PubMed Publisher
In one paragraph

Review in Familial cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 76 citations in OpenAlex.

  1. Peutz-Jeghers syndrome withoutWorld journal of gastroenterology · 2023
    Trial
  2. Cancers · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MalignantGynecologic oncology reports · 2024
    Article
  10. Article
  11. Review
  12. Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Hereditary cancer syndromes.World journal of clinical oncology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julian DaniellThe University of Melbourne, Melbourne, Australia. jdaniell@student.unimelb.edu.au.ORCID 0000-0001-8190-3663
John-Paul PlazzerThe Royal Melbourne Hospital, Melbourne, Australia.
Anuradha PereraThe University of Melbourne, Melbourne, Australia.
Finlay MacraeThe University of Melbourne, Melbourne, Australia.
The Royal Melbourne Hospital · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peutz-Jeghers Syndrome (PJS) is an autosomal dominant hereditary polyposis syndrome. Clinical features include hamartomatous polyps, mucocutaneous pigmentation and an increased predisposition towards developing malignancy. Variants in STK11, a tumour suppressor gene, located on Chromosome 19, predispose to PJS. Peutz-Jeghers Syndrome is associated with increased rates of malignancy, particularly gastrointestinal. However, PJS is also associated with increased gynaecological, testicular and thyroid papillary malignancy. Truncating variants in STK11 are thought to predispose to a more severe phenotype. Phenotype severity is based on earlier onset of gastrointestinal pathology arising from the polyps, such as intussusception or earlier onset malignancy. Missense variants are generally considered less severe than truncating variants. There remain a large number of variants of undetermined significance. Studies have attempted to correlate the location of variants with impact on protein structure and overall severity of the PJS phenotype. The results from these cohort studies have consistently found a non-random distribution of variants. Nevertheless, a consensus on phenotype severity based on variant location is yet to be established. A centralised database that collates all known variants would facilitate the interpretation of these variants, best under the governance of an international disease-specific organisation (InSiGHT). In particular, it could help explore the significance of variants based on their type or location. Understanding the genotype-phenotype link between STK11 variants and PJS could allow more personalised care for PJS patients and their families via appropriate risk stratification and personalised and targeted cancer screening.

Indexed as

AMP-Activated Protein Kinase KinasesFemaleGenetic Predisposition to DiseaseGenotypeHumansMalePeutz-Jeghers SyndromePhenotypeProtein Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesProtein Serine-Threonine KinasesSTK11 protein, humanHereditary tumour syndromeInSiGHTPeutz-Jeghers syndromeSTK11

Identifiers

PMID28900777
OpenAlexW2754389652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.